Cargando…

Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial

BACKGROUND: Combination therapies used to treat the photoaged skin have become more popular as studies demonstrate greater efficacy and improved clinical outcomes compared to single treatment modalities. OBJECTIVES: To evaluate the safety and effectiveness of treating the lateral canthal rhytide com...

Descripción completa

Detalles Bibliográficos
Autores principales: Tung, Rebecca, Mahoney, Anne Marie, Novice, Karlee, Kamalpour, Loebat, Dubina, Meghan, Hancock, Meredith, Krol, Cindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412106/
https://www.ncbi.nlm.nih.gov/pubmed/28491999
http://dx.doi.org/10.1016/j.ijwd.2015.12.006
_version_ 1783232921036914688
author Tung, Rebecca
Mahoney, Anne Marie
Novice, Karlee
Kamalpour, Loebat
Dubina, Meghan
Hancock, Meredith
Krol, Cindy
author_facet Tung, Rebecca
Mahoney, Anne Marie
Novice, Karlee
Kamalpour, Loebat
Dubina, Meghan
Hancock, Meredith
Krol, Cindy
author_sort Tung, Rebecca
collection PubMed
description BACKGROUND: Combination therapies used to treat the photoaged skin have become more popular as studies demonstrate greater efficacy and improved clinical outcomes compared to single treatment modalities. OBJECTIVES: To evaluate the safety and effectiveness of treating the lateral canthal rhytide complex with a Jessner’s and 35% TCA peel with and without pretreatment with BTX-A. METHODS: Twenty-six subjects with Fitzpatrick skin types I -III were randomized to receive treatment of their lateral canthal rhytide complex with a Jessner’s and 35% TCA peel with or without pretreatment with BTX-A. A single blinded dermatologist assigned a lateral canthal wrinkle score of subjects’ at baseline and week 8-10. RESULTS: Comparison between the two treatment groups demonstrated that the group receiving combination treatment had significantly greater improvement in wrinkle reduction as compared to the group only receiving the chemical peel (P =0.002). In addition, there was no significant association between skin type and treatment groups (P = 0.11). CONCLUSIONS: These findings suggest that treating the lateral canthal rhytide complex with a combination of BTX-A followed by Jessner’s and 35% TCA peel is more effective than chemical peel alone. These results are independent of skin type and demonstrate an additional treatment strategy for lateral canthal rhytides.
format Online
Article
Text
id pubmed-5412106
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54121062017-05-10 Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial Tung, Rebecca Mahoney, Anne Marie Novice, Karlee Kamalpour, Loebat Dubina, Meghan Hancock, Meredith Krol, Cindy Int J Womens Dermatol Article BACKGROUND: Combination therapies used to treat the photoaged skin have become more popular as studies demonstrate greater efficacy and improved clinical outcomes compared to single treatment modalities. OBJECTIVES: To evaluate the safety and effectiveness of treating the lateral canthal rhytide complex with a Jessner’s and 35% TCA peel with and without pretreatment with BTX-A. METHODS: Twenty-six subjects with Fitzpatrick skin types I -III were randomized to receive treatment of their lateral canthal rhytide complex with a Jessner’s and 35% TCA peel with or without pretreatment with BTX-A. A single blinded dermatologist assigned a lateral canthal wrinkle score of subjects’ at baseline and week 8-10. RESULTS: Comparison between the two treatment groups demonstrated that the group receiving combination treatment had significantly greater improvement in wrinkle reduction as compared to the group only receiving the chemical peel (P =0.002). In addition, there was no significant association between skin type and treatment groups (P = 0.11). CONCLUSIONS: These findings suggest that treating the lateral canthal rhytide complex with a combination of BTX-A followed by Jessner’s and 35% TCA peel is more effective than chemical peel alone. These results are independent of skin type and demonstrate an additional treatment strategy for lateral canthal rhytides. Elsevier 2016-03-28 /pmc/articles/PMC5412106/ /pubmed/28491999 http://dx.doi.org/10.1016/j.ijwd.2015.12.006 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Tung, Rebecca
Mahoney, Anne Marie
Novice, Karlee
Kamalpour, Loebat
Dubina, Meghan
Hancock, Meredith
Krol, Cindy
Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial
title Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial
title_full Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial
title_fullStr Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial
title_full_unstemmed Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial
title_short Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial
title_sort treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type a: a randomized control trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412106/
https://www.ncbi.nlm.nih.gov/pubmed/28491999
http://dx.doi.org/10.1016/j.ijwd.2015.12.006
work_keys_str_mv AT tungrebecca treatmentoflateralcanthalrhytideswithamediumdepthchemicalpeelwithorwithoutpretreatmentwithonabotulinumtoxintypeaarandomizedcontroltrial
AT mahoneyannemarie treatmentoflateralcanthalrhytideswithamediumdepthchemicalpeelwithorwithoutpretreatmentwithonabotulinumtoxintypeaarandomizedcontroltrial
AT novicekarlee treatmentoflateralcanthalrhytideswithamediumdepthchemicalpeelwithorwithoutpretreatmentwithonabotulinumtoxintypeaarandomizedcontroltrial
AT kamalpourloebat treatmentoflateralcanthalrhytideswithamediumdepthchemicalpeelwithorwithoutpretreatmentwithonabotulinumtoxintypeaarandomizedcontroltrial
AT dubinameghan treatmentoflateralcanthalrhytideswithamediumdepthchemicalpeelwithorwithoutpretreatmentwithonabotulinumtoxintypeaarandomizedcontroltrial
AT hancockmeredith treatmentoflateralcanthalrhytideswithamediumdepthchemicalpeelwithorwithoutpretreatmentwithonabotulinumtoxintypeaarandomizedcontroltrial
AT krolcindy treatmentoflateralcanthalrhytideswithamediumdepthchemicalpeelwithorwithoutpretreatmentwithonabotulinumtoxintypeaarandomizedcontroltrial